CVS Removes K.C. Pharma Eye Drops, Offers Full Refunds to Customers
CVS removes recalled eye drops and offers full refunds to affected customers.
Event / Health
K.C. Pharmaceuticals voluntarily recalled over 3.1 million bottles of eye drops in March due to sterility concerns. The FDA classified the recall as Class II. Products were sold under eight brand names at major retailers including CVS, Walgreens, and Kroger. No confirmed contamination or injuries reported.
2026-08-19 to 2026-11-16 · UTC publication dates
Coverage begins 4 Apr, 03:36 UTC
Follow the documented timeline or explore the related reporting.
K.C. Pharmaceuticals, Inc., based in Pomona, California, voluntarily recalled 3,111,072 bottles of eye drops on March 3 due to a "lack of assurance of sterility," meaning the products could potentially contain infection-causing microbes from the manufacturing process. The recall was classified as Class II by the FDA on March 31, indicating the products may cause temporary or medically reversible health consequences. No confirmed contamination or injuries have been reported to date.
CVS Health removed the recalled eye drop products from all CVS Pharmacy stores and CVS.com, placing a 'Do Not Sell' register prompt to prevent further sales. The company stated it was fully cooperating with the manufacturer's voluntary recall and offered customers the option to return purchased products to any CVS Pharmacy location for a refund.
The recalled eye drops were sold under brand names including Dry Eye Relief Eye Drops, Artificial Tears Sterile Lubricant Eye Drops, Sterile Eye Drops (various formulations), and Ultra Lubricating Eye Drops. Products were distributed at major retailers including CVS Health, Walgreens, Rite Aid, Kroger, H-E-B, Publix, Meijer, Harris Teeter, Dollar General, Circle K, and military exchanges, as well as through store brands like Best Choice, GeriCare, and Discount Drug Mart.
The largest batch in the recall involved 1,023,096 bottles of Dry Eye Relief Eye Drops (containing glycerin 0.2%, hypromellose 0.2%, and polyethylene glycol 400 1%), sold at retailers including Rite Aid, H-E-B, Meijer, Harris Teeter, and military exchanges. Most recalled bottles have expiration dates in May 2026 or October 2026.
The FDA officially classified the K.C. Pharmaceuticals eye drops recall as Class II on March 31, defining it as a recall where use of the affected product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
CVS removes recalled eye drops and offers full refunds to affected customers.
K.C. Pharmaceuticals recalls 3.1 million eye drop bottles across eight brands for sterility issues.